TGFB1 and cyclic hematopoiesis: Overall, our data demonstrate that Pip4k2c modRNA inhibits the mTORC1 pathway in CMs and the TGFβ1 pathway in cardiac fibroblasts post TAC, thereby reducing CH and CF, resulting in better cardiac function and survival following TAC injury (Figure S10, Supporting Information).